MicroPort CardioFlow Medtech Corporation (HKG:2160)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.660
-0.030 (-1.78%)
May 29, 2026, 4:08 PM HKT

MicroPort CardioFlow Medtech Company Description

MicroPort CardioFlow Medtech Corporation, together with its subsidiaries, researches, develops, manufactures, and sells medical devices for the treatment of structural heart disease and cardiac rhythm management in China, Europe, the Middle East, Africa, Asia, North America, and internationally.

The company offers VitaFlow, a transcatheter aortic valve system; VitaFlow Liberty, a transcatheter aortic valve retrievable and controllable bend delivery system; Alwide, a plus valve balloon dilation catheter; AccuSniper, a double-layer balloon dilation catheter, Angelguide, an advanced pre-shaped ultra-hard guidewire; and AnchorMan, a left atrial appendage occlusion and guidance system.

It also provides various active, mitral, and tricuspid valve products; left atrial appendage closure products; surgical accessories; low and high-voltage CRM products; leads and accessories; patient monitoring products; and arrhythmia diagnostic devices.

In addition, the company offers clinical solutions, including aortic stenosis and atrial fibrillation-related stroke prevention.

Further, it is involved in the manufacturing of raw materials for medical devices treating valvular heart diseases; and properties management.

The company was founded in 2009 and is headquartered in Shanghai, China.

MicroPort CardioFlow Medtech Corporation
CountryCayman Islands
Founded2009
IndustryMedical Devices
SectorHealthcare
Employees417
CEORuinian Zhang

Contact Details

Address:
No. 501 Niudun Road
Shanghai
China
Phone86 21 3895 4600
Websitecardioflowmedtech.com

Stock Details

Ticker Symbol2160
ExchangeHong Kong Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberKYG6082P1054
SIC Code3841

Key Executives

NamePosition
Ruinian ZhangChief Executive Officer, GM and Executive Director
Philippe WanstokPresident and Executive Director
Paul VoddenChief Financial Officer
Xiaoming ZhuChief Operating Officer
Alice FlaccoExecutive Vice President and General Counsel
Xiangmei LiJoint Company Secretary
Lok Yee Chan A.C.I.S., A.C.S.Joint Company Secretary